Anbio Biotechnology Class A Ordinary Shares (NNNN) — Net Asset Momentum
Anbio Biotechnology Class A Ordinary Shares (NNNN) recorded a net asset momentum of 75.4% as of December 2025, with net assets of $30.16 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See net assets of Anbio Biotechnology Class A Ordinary Sha for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Anbio Biotechnology Class A Ordinary Shares Net Asset Momentum (2021–2025)
This chart tracks Anbio Biotechnology Class A Ordinary Shares's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +75.4%, with net assets of $30.16 Million USD as of December 2025. For live market cap and overall valuation, see market cap of Anbio Biotechnology Class A Ordinary Sha.
Annual Net Asset History for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
The table below shows the complete annual net asset history for Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Anbio Biotechnology Class A Ordinary Sha (NNNN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $30.16 Million | $30.24 Million | $87.84K | ▲ +75.4% |
| 2024 | $17.19 Million | $18.92 Million | $1.73 Million | ▲ +16.0% |
| 2023 | $14.82 Million | $15.81 Million | $993.06K | ▲ +18.1% |
| 2022 | $12.55 Million | $13.96 Million | $1.41 Million | ▲ +394.8% |
| 2021 | $2.54 Million | $4.92 Million | $2.38 Million | — |